Hong Kong stock exchange filings reveal that on September 10, the board chairman increased his position in EVEREST MED by purchasing 20,000 shares.
The transaction was executed at a price of HKD 28.7065 per share, bringing the total investment to approximately HKD 574,100. Following this acquisition, the chairman's latest shareholding stands at around 2.18 million shares, representing a 0.62% ownership stake in the company.
This move signals continued confidence from the company's leadership amid ongoing market activity.